We are pleased to announce the first joint student symposium between the Cancer Research UK Convergence Science Centre at the ICR and Imperial, and the Institute of Chemical Biology’s Centre for Doctoral Training.
The symposium is split into three sessions of exciting research talks: ’Challenges in early detection’, ‘Development of novel therapeutics’ and finally, ‘What will work in the clinic’.
The meeting will be held on the 25th March 2020 from 9.30 – 17.20 (followed by a drinks reception from 17.30) at Imperial College London, Molecular Sciences Research Hub, White City Campus.
Novartis Oncology will also be in attendance, presenting on the role of industry in taking bench science to the clinic. They will be available during the poster session and evening reception to discuss opportunities in industry.
If you are an active student researcher in cancer detection, therapeutics, or clinical cancer research, we would be delighted to receive your abstract to present a poster; please email your title and abstract (max. 300 words) to ec1815@ic.ac.uk before the 22nd February 2020. Prizes will be awarded to posters that demonstrate excellent scientific communication and research impact.
Please follow the registration link to book your free place at our symposium by the 11th March 2020. Coffee, Lunch and Drinks reception provided.
Invited Speakers:
Prof. Ian McNeish – Chair in Oncology, Imperial College London
Dr. David Mann – Reader in Cell Cycle Control, Imperial College London – Covalent inhibitors for Oncology
Dr. Navita Somaiah – Clinical Oncologist, The Royal Marsden
Dr. Naureen Starling – Consultant Medical Oncologist, The Royal Marsden
Dr. James Warbuton – Medical Director, Novartis Oncology, Translating academic research into clincal candidates
Student Talks:
George West - Simulations of how ultrasound travels through tissue, to aid early-response assessment of tumours to radiotherapy .
Rhea Harewood – Identifying risk factors for proximal colon cancer
Thomas Pataillot-Meakin - Detection and Monitoring of Prostate cancer using circulating nucleic acid s
Ryan Howard – Identifying new druggable targets against necroptosis for tumorigenesis and metastasis
Cassandra Kennedy – Understanding MetAP2 inhibitors with chemical proteomics
Helena Dodd – Graphene oxide-templated biomolecular nanoclusters to control the Natural Killer cell anti-cancer response
We would like to thank Novartis Oncology, Cancer Research UK Convergence Science Centre and Institute of Chemical Biology-CDT for financial support.
Eventbrite disclaimer
We use Eventbrite to register seminar attendance in order to help us plan and manage events. Please note that Eventbrite is a third-party Cloud service, and does not provide the level of information security and data protection for your data you would normally expect from a College information service. We expect you to provide your full name and email address for this event, and you will have to register with the Eventbrite service as a personal consumer. Eventbrite will ask you to create an account with them using at least your first name, last name and your email address. Their terms and conditions state (in summary) that by doing so “[paragraph 17.1] you acknowledge and agree that you grant them full right and licence to use this information for the purpose of operating their Services (including Eventbrite’s promotional and marketing services).” Please also note that Eventbrite is a company registered in the United States, and the data you provide to them is most likely to be kept in the servers outside the European Union. As a result, if you prefer not to use the services provided by Eventbrite to register for this event, as an alternative please contact us at a.mcconnell@imperial.ac.uk directly providing your full name and email address and we will process your registration